Mycobacteria as Novel Immunomodulators

In this review, Immodulon along with academic collaborators charts the history of use of bacterial preparations, including mycobacterial products, as immunotherapeutic agents for the treatment of cancer and present evidence to explain the potential value of this approach.


Full title: William Coley’s legacy - the development of modern mycobacteria-based therapies for cancer

Journal: Trends in Cancer Research
Authors: Elia A., Rosa Brunet L., Hagemann T.

Date: September, 2013


Click here to read the abstract